Covered recipient · General Payments record
LACI M TARRANT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$652.58
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $420.28 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $237.96 | 10 |
| Axsome Therapeutics, Inc. | $63.92 | 1 |
| Lundbeck LLC | $27.83 | 1 |
| Insulet Corporation | $26.26 | 1 |
| Otsuka America Pharmaceutical, Inc. | $23.81 | 1 |
| Hologic Sales and Service, LLC | $13.95 | 1 |
| Lilly USA, LLC | $13.36 | 1 |
| Merck Sharp & Dohme Corporation | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.29 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287195 | CMS |
| ABBVIE INC. | $20.76 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287197 | CMS |
| ABBVIE INC. | $11.13 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287199 | CMS |
| ABBVIE INC. | $16.63 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287201 | CMS |
| ABBVIE INC. | $20.42 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287203 | CMS |
| ABBVIE INC. | $34.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287205 | CMS |
| ABBVIE INC. | $31.71 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287207 | CMS |
| ABBVIE INC. | $22.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287209 | CMS |
| ABBVIE INC. | $33.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287211 | CMS |
| ABBVIE INC. | $24.26 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287213 | CMS |
| Axsome Therapeutics, Inc. | $63.92 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148381490 | CMS |
| Hologic Sales and Service, LLC | $13.95 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084916128 | CMS |
| Insulet Corporation | $26.26 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116824830 | CMS |
| Lilly USA, LLC | $13.36 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135788204 | CMS |
| Lundbeck LLC | $27.83 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146097162 | CMS |
| Merck Sharp & Dohme LLC | $13.19 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141626889 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.81 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119197406 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.